ENTITY
Imugene Ltd

Imugene Ltd (IMU AU)

68
Analysis
Health Care • Australia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
bullish•BYD
•19 Sep 2021 07:20

Index Rebalance & ETF Flow Recap: STO/OSH, KEP/SPH, HHI, SET50, HSTECH, HSCI

This recap highlights Insights covering the index rebalance space in Asia as well as announcements that could result in index changes. We also look...

Logo
573 Views
Share
bullish•Steadfast
•17 Aug 2021 18:58

ASX100/200/300 Index Rebalance Preview: Big Impact & Large Shorts

There are a lot of changes expected across the ASX100, 200 & 300 indices at the September rebalance. A lot of those stocks will have a large impact...

Logo
577 Views
Share
bullish•Imugene Ltd
•12 Aug 2021 12:56

ASX300 Sep 2021 Index Rebalance Preview: Changes Galore

There could be 8 adds and 5 deletes to the ASX300 index at the September rebalance. The stocks have moved but the index is not very widely tracked,...

Logo
1.2k Views
Share
•05 Dec 2017 06:48

Aussie Healthcare Daily: 4 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
421 Views
Share
bearish•Macroeconomics
•01 Apr 2015 11:31

Taxing Times For Australia

The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...

Logo
6k Views
Share
x